News: Clinical Trial in Phase 2 is Testing a Vaccine for Celiac Disease
There is a significant news release today about a Phase 2 trial for a vaccine that might remove the fear of accidental gluten ingestion for millions of people with Celiac Disease. Many countries have done studies of the wellbeing of Celiac patients and discovered that the fear of accidental ingestion is the largest contributor to overall lowered wellbeing for people with Celiac Disease. Especially teenagers, who struggle to maintain a social life while being severely limited in what they can eat and drink. https://globenewswire.com/news-release/2018/10/30/1639162/0/en/ImmusanT-Initiates-Phase-2-Enrollment-for-its-Lead-Therapeutic-Vaccine-Candidate-in-Patients-With-Celiac-Disease-in-Australia-and-New-Zealand.html The company is called Immusan T and you can enroll in the US, Australia or New Zealand. Where to apply for enrollment: https://www.clinicaltrials.gov/ct2/show/NCT03644069?term=NCT03644069&rank=1 The name of the product is currently "Nexvax-2" Note tha